SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-19-106566
Filing Date
2019-04-15
Accepted
2019-04-15 16:18:02
Documents
7
Effectiveness Date
2019-04-15

Document Format Files

Seq Description Document Type Size
1 DEFA14A d682921ddefa14a.htm DEFA14A 38716
2 GRAPHIC g6829212a.jpg GRAPHIC 2392
3 GRAPHIC g682921snap0001_1.jpg GRAPHIC 1422
4 GRAPHIC g682921snap0002_2.jpg GRAPHIC 1284
5 GRAPHIC g682921snap0006_4.jpg GRAPHIC 1317
6 GRAPHIC g682921snap0007_5.jpg GRAPHIC 1309
7 GRAPHIC g682921snap0008_6.jpg GRAPHIC 1295
  Complete submission text file 0001193125-19-106566.txt   53021
Mailing Address 300 GEORGE STREET NEW HAVEN CT 06511
Business Address 300 GEORGE STREET NEW HAVEN CT 06511 203-624-7000
ACHILLION PHARMACEUTICALS INC (Filer) CIK: 0001070336 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-33095 | Film No.: 19748788
SIC: 2834 Pharmaceutical Preparations